Skip to content

Opening book details…

About this Medicine article

A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma by Wang-Gillam, Andrea; Plambeck-Suess, Stacey; Goedegebuure, Peter; Simon, Peter O.; Mitchem, Jonathan B.; Hornick, John R.; Sorscher, Steven; Picus, Joel; Suresh, Rama; Lockhart, Albert C.; Tan, Benjamin; Hawkins, Williams G. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Wang-Gillam, Andrea; Plambeck-Suess, Stacey; Goedegebuure, Peter; Simon, Peter O.; Mitchem, Jonathan B.; Hornick, John R.; Sorscher, Steven; Picus, Joel; Suresh, Rama; Lockhart, Albert C.; Tan, Benjamin; Hawkins, Williams G.
Publisher
Springer US; Springer-Verlag; Kluwer Academic Publishers; Springer Science and Business Media LLC (ISSN 0167-6997)
Published
2012
Field
Medicine (Health Sciences)

More by Wang-Gillam, Andrea; Plambeck-Suess, Stacey; Goedegebuure, Peter; Simon, Peter O.; Mitchem, Jonathan B.; Hornick, John R.; Sorscher, Steven; Picus, Joel; Suresh, Rama; Lockhart, Albert C.; Tan, Benjamin; Hawkins, Williams G.

Browse all works by Wang-Gillam, Andrea; Plambeck-Suess, Stacey; Goedegebuure, Peter; Simon, Peter O.; Mitchem, Jonathan B.; Hornick, John R.; Sorscher, Steven; Picus, Joel; Suresh, Rama; Lockhart, Albert C.; Tan, Benjamin; Hawkins, Williams G.